QU scientists in precision medicine breakthrough - Gulf Times
Qatar University scientists developed Apabetalone, an epigenetic therapy targeting gene regulation for treating chronic diseases, granted FDA breakthrough designation. Led by Dr. Zaid al-Ma'ayah, the study, published in Pharmacology and Translational Science, explores Apabetalone's potential in cardiovascular, renal, neurological, viral, and cancer disorders, funded by QU.
Reference News
Qatar University scientists developed Apabetalone, an epigenetic therapy targeting gene regulation for treating chronic diseases, granted FDA breakthrough designation. Led by Dr. Zaid al-Ma'ayah, the study, published in Pharmacology and Translational Science, explores Apabetalone's potential in cardiovascular, renal, neurological, viral, and cancer disorders, funded by QU.